Randy Maloziec featured in Rare Disease Report article: "Fostamatinib Disodium Hexahydrate Tablet to Be Dispensed by US Bioservices for ITP"

|

Rigel Pharmaceuticals has recently selected US Bioservices to dispense fostamatinib disodium hexahydrate (TAVALISSE) tablets, for the treatment of adult patients with chronic immune thrombocytopenia (ITP), a rare blood disorder, who have had an insufficient response to a previous treatment.